Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Thoracic 2Head & Neck 2Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Mixed Dementias 1Lymphoma, Follicular 1Lewy Body Disease 1Dementia, Vascular 1Dementia 1Cognitive Dysfunction 1

Interventions

Cyclophosphamide 170Rituximab 164Specimen Handling 116Biopsy 92Magnetic Resonance Spectroscopy 90Vincristine 86Doxorubicin 81Prednisone 78fludarabine 70venetoclax 69obinutuzumab 62ibrutinib 55Lenalidomide 55Dexamethasone 55Cytarabine 49Methotrexate 47acalabrutinib 44Etoposide 43CT-P10 42blinatumomab 38fludarabine phosphate 35Bendamustine Hydrochloride 34Gemcitabine 33zanubrutinib 31prednylidene 31pembrolizumab 30glofitamab 30deltacortene 30Calcium Dobesilate 30Nivolumab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Referral and Consultation × Lymphoid × 90 days × Clear all
NCT05860127 2026-03-23

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

University of Massachusetts, Amherst

Phase NA Completed
133 enrolled 14 charts
Lymphoid

Mixed Dementias, Dementia, Lymphoma, Follicular, Dementia, Vascular, Lewy Body Disease, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡